Article

Tyrosine Kinase Inhibitor Family of Drugs as Prospective Targeted Therapy for COVID-19 Based on <i>In Silico</i> And 3D-Human Vascular Lung Model Studies

2021-05-14

Abstract excerpt

COVID-19 pandemic has ravaged the world and vaccines have been rapidly developed as preventive measures. But there is no target-based therapy which can be used if infection sets in. Remdesiver and dexamethasone were not designed to combat COVID-19 but are used clinically till better targeted therapies are available. Given this situation target based therapies that intervene in the disease pathway are urgently need...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 0d38032d-9efd-5dad-ab44-096230f64e62
DOI: 10.1101/2021.05.13.443955

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Tyrosine Kinase Inhibitor Family of Drugs as Prospective Targeted Therapy for COVID-19 Based on <i>In Silico</i> And 3D-Human Vascular Lung Model StudiesDOI 10.1101/2021.05.13.443955Read

Drug-repurposing against COVID-19 by targeting a key signaling pathway: An in silico studySemantic proximity Read

Advances in Targeting ACE2 for Developing COVID-19 TherapeuticsSemantic proximity Read

DEVELOPING NEW DUAL-ACTION ANTIVIRAL/ANTI-INFLAMMATORY SMALL MOLECULES FOR COVID-19 TREATMENT USING IN SILICO AND IN-VITRO APPROACHESSemantic proximity Read

The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligandsSemantic proximity Read

Advances in Bruton tyrosine kinase (Btk) inhibition are steered by Bruton tyrosine kinase phylogenySemantic proximity Read

Drug repurposing for COVID-19 using computational screening: Is Fostamatinib/R406 a potential candidate?Semantic proximity Read

Repurposing alpelisib, an anti-cancer drug, for the treatment of severe TIE2-mutated venous malformations: preliminary pharmacokinetics and pharmacodynamic dataSemantic proximity Read

The Journey of DDR1 and DDR2 Kinase Inhibitors as Rising Stars in the Fight Against CancerSemantic proximity Read

Human cell receptors: potential drug targets to combat COVID-19Semantic proximity Read

Omics Based Screening of novel inhibitors against malignant pleural mesotheliomaSemantic proximity Read

Real-World Data Analysis of Vascular and Lymphatic Adverse Events Associated with Anti-Tumor Angiogenesis Drugs: A WHO-VigiAccess StudySemantic proximity Read

Current application status and structure–activity relationship of selective and non-selective JAK inhibitors in diseasesSemantic proximity Read